Target intelligence / Profile preview

RNA, U4 small nuclear 65, pseudogene (RNU4-65P)

Target: RNU4-65P
Molecular classification: Other (Pseudogene), Non-coding RNA (Pseudogene annotation, not a functional snRNA)

Overview

RNA, U4 small nuclear 65, pseudogene (RNU4-65P) is a non-protein-coding pseudogene annotated in the human genome. It does not produce a functional small nuclear RNA or protein. While functional U4 snRNA is an essential component of the spliceosome in RNA splicing and is implicated in neurodevelopmental disorders when mutated (such as RNU4-2), RNU4-65P itself is considered non-functional and has no biological, pharmacological, or clinical relevance as a therapeutic target[1][5][7].

Beyond the preview

Go deeper on RNA, U4 small nuclear 65, pseudogene (RNU4-65P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 65, pseudogene (RNU4-65P).

Explore the full profile